Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Inadomi

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
The American Journal of Gastroenterology|December 4, 2009
Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinomaJoel H Rubenstein, John M Inadomi
JAMA|April 27, 2017
Follow-up of Positive Fecal Test Results: Sooner Is Better, but How Much Better?Carolyn M Rutter, John M Inadomi
JAMA Internal Medicine|March 13, 2013
Anesthesia for colonoscopy: too much of a good thing?Karen J Wernli, John M Inadomi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2005
PPI use in the OTC era: who to treat, with what, and for how long?John M Inadomi, A Mark Fendrick
Gastrointestinal Endoscopy|June 4, 2005
Dysphagia drives doctors to diagnose a disease: pitfalls in interpreting observational studiesJoel H Rubenstein, John M Inadomi
JAMA|August 2, 2017
Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test-ReplyCarolyn M Rutter, John M Inadomi
Hepatology (Baltimore, Md.)|January 24, 2003
Empiric beta-blockers for the prophylaxis of variceal hemorrhage: cost effective or clinically applicable?Joel H Rubenstein, John M Inadomi
The American Journal of Gastroenterology|September 6, 2006
Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patientsJoel J Heidelbaugh, John M Inadomi
Gastroenterology|May 9, 2007
Proton pump inhibitors and hip fracture: cause for alarm?John M Inadomi, M A Somsouk
Journal of Clinical Gastroenterology|January 6, 2006
Defining a clinically significant adverse impact of diagnosing Barrett's esophagusJoel H Rubenstein, John M Inadomi
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
The American Journal of Gastroenterology|December 4, 2009
Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinomaJoel H Rubenstein, John M Inadomi
JAMA|April 27, 2017
Follow-up of Positive Fecal Test Results: Sooner Is Better, but How Much Better?Carolyn M Rutter, John M Inadomi
JAMA Internal Medicine|March 13, 2013
Anesthesia for colonoscopy: too much of a good thing?Karen J Wernli, John M Inadomi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2005
PPI use in the OTC era: who to treat, with what, and for how long?John M Inadomi, A Mark Fendrick
Gastrointestinal Endoscopy|June 4, 2005
Dysphagia drives doctors to diagnose a disease: pitfalls in interpreting observational studiesJoel H Rubenstein, John M Inadomi
JAMA|August 2, 2017
Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test-ReplyCarolyn M Rutter, John M Inadomi
Hepatology (Baltimore, Md.)|January 24, 2003
Empiric beta-blockers for the prophylaxis of variceal hemorrhage: cost effective or clinically applicable?Joel H Rubenstein, John M Inadomi
The American Journal of Gastroenterology|September 6, 2006
Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patientsJoel J Heidelbaugh, John M Inadomi
Gastroenterology|May 9, 2007
Proton pump inhibitors and hip fracture: cause for alarm?John M Inadomi, M A Somsouk
Journal of Clinical Gastroenterology|January 6, 2006
Defining a clinically significant adverse impact of diagnosing Barrett's esophagusJoel H Rubenstein, John M Inadomi
Pageof 17